title: A review of the FDA draft guidance document for software validation: guidance for industry.
abstract: A Draft Guidance Document (Version 1.1) was issued by the United States Food and Drug Administration (FDA) to address the software validation requirement of the Quality System Regulation, 21 CFR Part 820, effective June 1, 1997. The guidance document outlines validation considerations that the FDA regards as applicable to both medical device software and software used to "design, develop or manufacture" medical devices. The Draft Guidance is available at the FDA web site http:@www.fda.gov/cdrh/comps/swareval++ +.html. Presented here is a review of the main features of the FDA document for Quality System Regulation (QSR), and some guidance for its implementation in industry.
authors.affiliation: Colorado Analytical Research & Development Corporation, Colorado Springs 80907, USA. klkeat@juno.com
authors.forename: K L
authors.initials: KL
authors.lastname: Keatley
mesh_terms: D017408:Guidelines as Topic; D006801:Humans; D012986:Software Validation; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*